Literature DB >> 17874208

Sebaceous adenomas in an MYH associated polyposis patient of Indian (Gujarati) origin.

Vadakke Kanakath Ajith Kumar1, June Anne Gold, Eleanor Mallon, Shyamala Thomas, Shirley V Hodgson.   

Abstract

MYH associated polyposis is an autosomal recessive polyposis syndrome with a high risk of large bowel cancer, caused by mutations in the DNA repair gene MYH. Founder mutations have been described in different ethnic groups. Muir Torre Syndrome is the association of internal malignancies with sebaceous gland tumours; Lynch Syndrome/Hereditary Non Polyposis Cancer is the best known cause. There has been a previous report of sebaceous gland tumours in an Italian patient with MYH associated polyposis. We describe a man of Indian (Gujarati) descent who has MYH associated polyposis and multiple sebaceous adenomas of the skin.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17874208     DOI: 10.1007/s10689-007-9161-9

Source DB:  PubMed          Journal:  Fam Cancer        ISSN: 1389-9600            Impact factor:   2.375


  6 in total

1.  Attenuated familial adenomatous polyposis and Muir-Torre syndrome linked to compound biallelic constitutional MYH gene mutations.

Authors:  G Ponti; M Ponz de Leon; S Maffei; M Pedroni; L Losi; C Di Gregorio; V Gismondi; A Scarselli; P Benatti; B Roncari; S Seidenari; G Pellacani; C Varotti; E Prete; L Varesco; L Roncucci
Journal:  Clin Genet       Date:  2005-11       Impact factor: 4.438

2.  Inherited variants of MYH associated with somatic G:C-->T:A mutations in colorectal tumors.

Authors:  Nada Al-Tassan; Nikolas H Chmiel; Julie Maynard; Nick Fleming; Alison L Livingston; Geraint T Williams; Angela K Hodges; D Rhodri Davies; Sheila S David; Julian R Sampson; Jeremy P Cheadle
Journal:  Nat Genet       Date:  2002-01-30       Impact factor: 38.330

3.  A kindred with MYH-associated polyposis and pilomatricomas.

Authors:  Silvana Baglioni; German Melean; Francesca Gensini; Marco Santucci; Marco Scatizzi; Laura Papi; Maurizio Genuardi
Journal:  Am J Med Genet A       Date:  2005-04-15       Impact factor: 2.802

4.  Autosomal recessive colorectal adenomatous polyposis due to inherited mutations of MYH.

Authors:  Julian R Sampson; Sunil Dolwani; Sian Jones; Diana Eccles; Anthony Ellis; D Gareth Evans; Ian Frayling; Sheila Jordan; Eamonn R Maher; Tony Mak; Julie Maynard; Francesca Pigatto; Joan Shaw; Jeremy P Cheadle
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

5.  Comprehensive analysis of the contribution of germline MYH variation to early-onset colorectal cancer.

Authors:  Christina Fleischmann; Julian Peto; Jeremy Cheadle; Bindiya Shah; Julian Sampson; Richard S Houlston
Journal:  Int J Cancer       Date:  2004-04-20       Impact factor: 7.396

6.  Prevalence of the Y165C, G382D and 1395delGGA germline mutations of the MYH gene in Italian patients with adenomatous polyposis coli and colorectal adenomas.

Authors:  Viviana Gismondi; Maurizio Meta; Luigina Bonelli; Paolo Radice; Paola Sala; Lucio Bertario; Alessandra Viel; Mara Fornasarig; Arrigo Arrigoni; Mattia Gentile; Maurizio Ponz de Leon; Luca Anselmi; Cristina Mareni; Paolo Bruzzi; Liliana Varesco
Journal:  Int J Cancer       Date:  2004-05-01       Impact factor: 7.396

  6 in total
  10 in total

1.  Cancer risks for monoallelic MUTYH mutation carriers with a family history of colorectal cancer.

Authors:  Aung Ko Win; Sean P Cleary; James G Dowty; John A Baron; Joanne P Young; Daniel D Buchanan; Melissa C Southey; Terrilea Burnett; Patrick S Parfrey; Roger C Green; Loïc Le Marchand; Polly A Newcomb; Robert W Haile; Noralane M Lindor; John L Hopper; Steven Gallinger; Mark A Jenkins
Journal:  Int J Cancer       Date:  2011-04-08       Impact factor: 7.396

2.  French experts report on MUTYH-associated polyposis (MAP).

Authors:  Bruno Buecher; Catherine Bonaïti; Marie-Pierre Buisine; Chrystelle Colas; Jean-Christophe Saurin
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

Review 3.  Sebaceous neoplasia and the Muir-Torre syndrome: important connections with clinical implications.

Authors:  Sara C Shalin; Stephen Lyle; Eduardo Calonje; Alexander J F Lazar
Journal:  Histopathology       Date:  2010-01       Impact factor: 5.087

Review 4.  Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model.

Authors:  Henry T Lynch; Jane F Lynch; Thomas A Attard
Journal:  CMAJ       Date:  2009-08-04       Impact factor: 8.262

5.  Papillary thyroid cancer in a patient with MUTYH-associated polyposis (MAP).

Authors:  Muhammad Ali Pervaiz; Amanda Eppolito; Karen Schmidt
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

6.  Biallelic MYH germline mutations as cause of Muir-Torre syndrome.

Authors:  Carmen Guillén-Ponce; Adela Castillejo; Víctor M Barberá; J Carlos Pascual-Ramírez; Encarnación Andrada; M Isabel Castillejo; Carla Guarinós; M J Molina-Garrido; Alfredo Carrato; J L Soto
Journal:  Fam Cancer       Date:  2010-06       Impact factor: 2.375

Review 7.  Sebaceous Carcinoma: A Review of the Scientific Literature.

Authors:  Thomas Knackstedt; Faramarz H Samie
Journal:  Curr Treat Options Oncol       Date:  2017-08

8.  MUTYH-associated polyposis (MAP): evidence for the origin of the common European mutations p.Tyr179Cys and p.Gly396Asp by founder events.

Authors:  Stefan Aretz; Rossella Tricarico; Laura Papi; Isabel Spier; Elisa Pin; Sukanya Horpaopan; Emanuela Lucci Cordisco; Monica Pedroni; Dietlinde Stienen; Annamaria Gentile; Anna Panza; Ada Piepoli; Maurizio Ponz de Leon; Waltraut Friedl; Alessandra Viel; Maurizio Genuardi
Journal:  Eur J Hum Genet       Date:  2013-01-30       Impact factor: 4.246

9.  MUTYH Associated Polyposis (MAP).

Authors:  M L M Poulsen; M L Bisgaard
Journal:  Curr Genomics       Date:  2008-09       Impact factor: 2.236

10.  Risk of extracolonic cancers for people with biallelic and monoallelic mutations in MUTYH.

Authors:  Aung Ko Win; Jeanette C Reece; James G Dowty; Daniel D Buchanan; Mark Clendenning; Christophe Rosty; Melissa C Southey; Joanne P Young; Sean P Cleary; Hyeja Kim; Michelle Cotterchio; Finlay A Macrae; Katherine M Tucker; John A Baron; Terrilea Burnett; Loïc Le Marchand; Graham Casey; Robert W Haile; Polly A Newcomb; Stephen N Thibodeau; John L Hopper; Steven Gallinger; Ingrid M Winship; Noralane M Lindor; Mark A Jenkins
Journal:  Int J Cancer       Date:  2016-06-02       Impact factor: 7.316

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.